Paper: opening our stem cell collection to the world
In the Ooi lab we have over the years grown our induced pluripotent stem cell (iPSC) portfolio. In 2018 we...
Paper: Liraglutide prevents metabolic side-effects and improves recognition and working memory during antipsychotic treatment in rats.
Some progress in my neuropharmacology portfolio of novel treatment options: we have just published our assessment of Liraglutide to combat...
Paper: Unmasking the true identity in neuron differentiation
Just weeks after our review on problems with current differentiation protocols, a method for iPSC-derived cholinergic neurons got published in...
Paper: Common pitfalls of stem cell differentiation: a guide to improving protocols for neurodegenerative disease models and research
Differentiating stem cells into neurons is gaining more and more traction, but is still a very challenging task. We have...
Paper: mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia
We published our preclinical antipsychotic study with my PhD supersivors and fellow PhD students. We show with this work, that the...
Paper: Metabotropic glutamate receptor 5 and its trafficking molecules, Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia
Our manuscript on altered mGluR5 expression and signaling in individuals with schizophrenia just got published in Schizophrenia Research: Metabotropic glutamate receptor...
Paper: Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation
Our manuscript on altered mGluR5 expression and signaling in individuals with schizophrenia just got published in Acta Neuropathologica: Alterations of mGluR5...